SecBot SecBot
8-K ·Filed Apr 17, 2026

PETVW

PetVivo Holdings, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed6mo ago SEC0001493152-26-017819
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

Monitor for additional $1.5 million drawdown by June 15, 2026, which would further dilute shares. The repeated need for dilutive financing suggests cash flow challenges, potentially pressuring the stock price despite funding commercialization efforts.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

PetVivo Holdings raised $1 million through a private placement of 1.25 million units at $0.80 per unit, with each unit consisting of one share of common stock and one warrant to purchase an additional share at $1.10. The company also granted the investor an option to purchase up to $1.5 million more in equity on the same terms by June 15, 2026. Proceeds will fund commercialization of its lead product, new product development, and general corporate purposes.

Key Financial Metrics

Offering Size
$1.0M

Key Facts

  • Raised $1 million through private placement of 1.25 million units at $0.80 per unit
  • Each unit includes one share of common stock and one warrant exercisable at $1.10 per share for three years
  • Investor granted option to purchase up to $1.5 million more in equity by June 15, 2026
  • Proceeds to fund commercialization of Spryng™ with OsteoCushion™ Technology, new product development, clinical trials, and working capital
  • Offering conducted under Section 4(a)(2) and Regulation D exemptions for accredited investors only

Financial Impact

Raises $1 million immediately with potential for $1.5 million more, diluting existing shareholders. The $0.80 price represents a discount to market value, increasing dilution impact.

dilutioncashequity

Risk Factors

  • Significant shareholder dilution from current and potential future equity issuance
  • Dependence on continued dilutive financing indicates possible cash flow problems
  • Warrants exercisable at $1.10 could create downward pressure on stock price if market price approaches that level

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-017819
Document: form8-k.htm0001493152-26-017819
Document: 0001493152-26-017819-index-headers.html0001493152-26-017819
Document: 0001493152-26-017819-index.html0001493152-26-017819
Document: 0001493152-26-017819.txt0001493152-26-017819
2 reports for PETVW
Performance horizon
Filters
Rows
Reports for PETVW — sortable, filterable
TypeNow
Apr 17, 2026
27w ago
8-K
BEARISH ★ 6/10
—awaiting T+20——
Mar 27, 2026
30w ago
8-K/A
BEARISH ★ 6/10
—awaiting T+20——
Showing 2 of 2

US Market Status

Market Closed — Opens Tue (17h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026